Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning.
about
Reduced-intensity and myeloablative conditioning allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome: a meta-analysis and systematic reviewDonor Chimerism of B Cells and Nature Killer Cells Provides Useful Information to Predict Hematologic Relapse following Allogeneic Hematopoietic Stem Cell Transplantation.Mixed T Lymphocyte Chimerism after Allogeneic Hematopoietic Transplantation Is Predictive for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes.Dynamical System Modeling of Immune Reconstitution after Allogeneic Stem Cell Transplantation Identifies Patients at Risk for Adverse Outcomes.Reduced-intensity conditioned allogeneic SCT in adults with AML.Reduced-intensity conditioning with fludarabine and busulfan for allogeneic hematopoietic cell transplantation in elderly or infirm patients with advanced myeloid malignancies.Allogeneic hematopoietic cell transplantation in patients with myelofibrosis: A single center experience.Use of killer cell immunoglobulin-like receptor genes as early markers of hematopoietic chimerism after double-umbilical cord blood transplantation.PD-L1 Prevents the Development of Autoimmune Heart Disease in Graft-versus-Host Disease.Pharmacodynamic Monitoring Predicts Outcomes of CCR5 Blockade as Graft-versus-Host Disease Prophylaxis.Early mixed T-cell chimerism is predictive of pediatric AML or MDS relapse after hematopoietic stem cell transplant.
P2860
Q34770016-CC560697-6B51-4EF9-AF4A-73373F538ECAQ35726470-92BDC0B6-5DD9-41AE-A7AA-8217D42AEC06Q36157233-859F9B1C-FF14-4CCB-A289-5804BBB5A4BAQ36812102-47D63324-FEB1-431E-8BF4-67512AA5DC4CQ38366632-11351B08-38C2-4E96-8826-091B404608C5Q40494657-3FBC6566-1EE9-46C2-A301-BD0FF07E15BCQ40829969-D4A1F87B-ABB5-4AD8-9B23-15BB38FC6604Q42910839-5DEC404A-1680-4E6D-A513-38EE6CD5B8DFQ48165202-F1F16FE0-EC07-4C44-BC6B-A3FE811DE9ECQ48622749-126C8CFA-DD40-44B7-AA48-C2BFCD345B80Q52783570-D6FAA711-84F7-46FA-B128-CA6061B828F5
P2860
Early donor chimerism levels predict relapse and survival after allogeneic stem cell transplantation with reduced-intensity conditioning.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Early donor chimerism levels p ...... educed-intensity conditioning.
@ast
Early donor chimerism levels p ...... educed-intensity conditioning.
@en
Early donor chimerism levels p ...... educed-intensity conditioning.
@nl
type
label
Early donor chimerism levels p ...... educed-intensity conditioning.
@ast
Early donor chimerism levels p ...... educed-intensity conditioning.
@en
Early donor chimerism levels p ...... educed-intensity conditioning.
@nl
prefLabel
Early donor chimerism levels p ...... educed-intensity conditioning.
@ast
Early donor chimerism levels p ...... educed-intensity conditioning.
@en
Early donor chimerism levels p ...... educed-intensity conditioning.
@nl
P2093
P2860
P1476
Early donor chimerism levels p ...... educed-intensity conditioning.
@en
P2093
Alison W Loren
David L Porter
Edward A Stadtmauer
Elizabeth O Hexner
Jacqueline Smith
James K Mangan
Kathryn A Lafferty
Noelle V Frey
Pavel Vassilev
Ran Reshef
P2860
P304
P356
10.1016/J.BBMT.2014.07.003
P577
2014-07-10T00:00:00Z